The Global Pharmaceutical Grade Sodium Hyaluronic Acid Market was valued at USD 1.16 Billion in 2026 and is projected to reach USD 1.85 Billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period (2025-2034). This growth is being driven by the rising demand for osteoarthritis treatments, increasing aesthetic procedures, and expanding applications in ophthalmic surgeries and wound care.

As the medical and cosmetic industries continue to demand high-purity hyaluronic acid solutions, pharmaceutical-grade raw material suppliers are innovating with advanced fermentation technologies and purification processes. In this blog, we profile the Top 10 Companies in the Pharmaceutical Grade Sodium Hyaluronic Acid Industry—biotech innovators and established manufacturers shaping the future of medical-grade HA supply.

---

🔟 10. Shandong Runxin Biotechnology

Headquarters: Jinan, China
Key Offering: High and low molecular weight HA, Oligomeric HA

Shandong Runxin is a pioneering Chinese manufacturer specializing in pharmaceutical-grade sodium hyaluronic acid through microbial fermentation technology. The company supplies raw materials for dermal fillers, orthopedic injections, and ophthalmic viscoelastic products.

Key Strengths:

• 10+ years of pharmaceutical HA production experience
• FDA and CE certified manufacturing facilities
• Annual production capacity exceeding 50 metric tons

Download FREE Sample Report: Pharmaceutical Grade Sodium Hyaluronic Acid Raw Material Market – View in Detailed Research Report

---

9️⃣ 9. Sinco Pharmachem

Headquarters: Changzhou, China
Key Offering: USP Grade HA, Ultra-pure HA for injectables

Sinco Pharmachem has emerged as a reliable supplier of high-quality pharmaceutical-grade sodium hyaluronic acid, particularly for international markets. Their products meet strict pharmacopeia standards for endotoxin levels and molecular weight consistency.

Key Strengths:

• Specializes in low endotoxin (<0.05 EU/mg) formulations
• GMP certified production lines
• Strong presence in Asian and European markets

---

8️⃣ 8. Shandong Focusfreda Biotech

Headquarters: Jinan, China
Key Offering: Cross-linked HA, Medical device-grade HA

This Chinese biotech company has made significant investments in pharmaceutical-grade HA production, with particular expertise in cross-linked formulations that provide extended duration for medical aesthetics applications.

Key Strengths:

• Vertically integrated production from fermentation to finished API
• ISO 13485 certified for medical device applications
• R&D focus on advanced wound care formulations

---

7️⃣ 7. Ivy Fine Chemicals

Headquarters: North Brunswick, USA
Key Offering: Research-grade HA, Custom HA formulations

Ivy Fine Chemicals serves the North American pharmaceutical and biotechnology sectors with high-purity sodium hyaluronic acid raw materials. They specialize in small-batch, customized molecular weight HA for drug delivery research.

Key Strengths:

• FDA-registered facility
• Specializes in oligomeric HA for advanced drug delivery
• Strong technical support for formulation development

Download FREE Sample Report: Pharmaceutical Grade Sodium Hyaluronic Acid Raw Material Market – View in Detailed Research Report

---

6️⃣ 6. BOC Sciences

Headquarters: Shirley, USA
Key Offering: High Purity HA, HA derivatives for drug delivery

BOC Sciences supplies pharmaceutical-grade sodium hyaluronic acid to global pharmaceutical companies and research institutions. Their product portfolio includes various molecular weights tailored for specific medical applications.

Key Strengths:

• Comprehensive analytical characterization services
• Special HA derivatives for conjugation chemistry
• Global distribution network

---

5️⃣ 5. Sigma-Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical excipient HA, Research-grade HA

As part of the Merck KGaA life science division, Sigma-Aldrich provides high-quality sodium hyaluronic acid to the global pharmaceutical and biotechnology industries, with stringent quality controls meeting international pharmacopeia standards.

Key Strengths:

• Global regulatory compliance expertise
• Documented cGMP manufacturing
• Extensive quality control testing

---

4️⃣ 4. Bloomage Biotechnology

Headquarters: Jinan, China
Key Offering: HA for medical devices, Injectable-grade HA

Bloomage has grown to become one of the world’s largest producers of pharmaceutical-grade sodium hyaluronic acid, with significant capacity dedicated to medical applications. The company supplies major dermal filler manufacturers globally.

Key Strengths:

• World’s largest HA production capacity
• Vertically integrated manufacturing
• Strong intellectual property portfolio

---

3️⃣ 3. Biosynth

Headquarters: Staad, Switzerland
Key Offering: Ultra-pure HA, HA for drug conjugates

Biosynth specializes in high-purity sodium hyaluronic acid for pharmaceutical applications, with particular expertise in HA-drug conjugate development and characterization services.

Key Strengths:

• EMEA regulatory expertise
• FDA Drug Master Files for multiple HA products
• Custom molecular weight specifications

Read Full Report: Pharmaceutical Grade Sodium Hyaluronic Acid Raw Material Market – View in Detailed Research Report

---

2️⃣ 2. Contipro

Headquarters: Dolní Dobrouč, Czech Republic
Key Offering: Specialty HA fractions, Medical device HA

Contipro has established itself as a technology leader in hyaluronic acid innovation, developing proprietary fermentation and processing technologies that yield highly consistent pharmaceutical-grade products.

Key Strengths:

• Proprietary fermentation technology
• High-molecular-weight HA expertise
• Strong IP portfolio with 100+ HA patents

---

1️⃣ 1. Kewpie Corporation

Headquarters: Tokyo, Japan
Key Offering: High-purity HA, HA for ophthalmic surgery

Kewpie is recognized as the global leader in pharmaceutical-grade sodium hyaluronic acid, with decades of experience in HA production for medical applications. Their products set the industry standard for purity and consistency.

Key Strengths:

• Industry-leading purity standards (<0.01% protein)
• Pioneer in bacterial fermentation HA production
• Preferred supplier for critical medical applications

---

🔬 Outlook: The Future of Pharmaceutical Grade HA is Diversified and Innovative

The pharmaceutical grade sodium hyaluronic acid market is undergoing significant transformation as new medical applications emerge and manufacturing technologies advance. While traditional uses in joint health and dermal fillers continue to drive demand, innovative applications in drug delivery and regenerative medicine are creating new growth opportunities.

📈 Key Trends Shaping the Market:

• Increasing adoption of microbial fermentation over animal-derived extraction
• Growing demand for ultra-pure HA with endotoxin levels below 0.05 EU/mg
• Expansion of HA applications in cancer therapeutics and gene delivery
• Development of HA derivatives with enhanced functionality

Read Full Report: Pharmaceutical Grade Sodium Hyaluronic Acid Raw Material Market – View in Detailed Research Report

The companies profiled above are not only supplying critical raw materials—they’re driving the innovation that will shape the future of hyaluronic acid applications in medicine and aesthetics.